This test is most useful if any of these apply to you.
Bartonella is a slippery infection. It can sit in your bloodstream at very low levels for months or years, dodging routine blood cultures and sometimes even antibody tests, while quietly contributing to fevers, heart valve infections, neurologic symptoms, and chronic illness in some people. This test looks directly for the bacterium's genetic fingerprint in your blood using PCR (a lab method that amplifies tiny amounts of DNA so they can be detected).
If you have an unexplained fever, a heart valve infection that keeps culturing negative, a known exposure through cats, fleas, or lice (ticks have been investigated as a possible vector but transmission to people is not firmly established), or you are immune compromised and serology might miss the infection, a direct DNA test gives you a different angle on the question. It can confirm an active bloodstream infection, but it cannot rule one out, and that distinction shapes how you should use the result.
This is a blood PCR test that searches for fragments of Bartonella DNA in your blood. The lab amplifies short sequences from genes such as ssrA, gltA, rpoB, the 16S rRNA gene, or the spacer region between bacterial ribosome genes (the 16S to 23S internal transcribed spacer). When the assay finds a match, sequencing can usually identify the species, including B. henselae (the cat-scratch organism), B. quintana (trench fever), B. vinsonii subsp. berkhoffii, B. bacilliformis, and others.
The test does not measure a hormone or a protein your body makes. It measures the bacterium itself, or fragments of it, in your circulation. That makes a positive result meaningful in the right clinical setting, because the DNA had to come from somewhere. Bartonella prefers to live inside red blood cells and along the inner lining of blood vessels (endothelial cells), and from those niches it can release small numbers of organisms or DNA into the blood in waves.
This is the most important fact about Bartonella DNA testing. The bacterium causes a relapsing, low-level bacteremia that can sit below the detection limit of conventional PCR assays. Bartonella is also fastidious and slow-growing, with primary isolation on agar taking up to four weeks, so culture-based confirmation is hard. The result is that a single negative blood PCR does not exclude infection, and the literature explicitly states this.
How much detection depends on technique was shown in a 500-person Brazilian blood-donor study. Conventional culture-plus-PCR identified 3.2% of donors as infected. When the same donors were retested with multiple molecular assays paired with liquid enrichment culture, Bartonella DNA was detected in 20.4% by at least one PCR method. Same blood, very different yield.
To improve sensitivity, expert labs often draw blood three times across five to seven days, combine direct PCR with enrichment culture, and use multiple gene targets or newer methods such as digital PCR. In one study of suspected bartonellosis, nested PCR targeting the FtsZ gene detected B. henselae DNA in 15 of 18 patients (83.3%) and outperformed nested PCR targeting other regions.
Bartonella is a recognized cause of blood culture-negative endocarditis (an infection of a heart valve where standard blood cultures fail to grow anything). In a prospective study of 819 such cases, blood-based serology and PCR identified zoonotic causes, including Bartonella, in a substantial share of patients. Blood PCR specifically had limited sensitivity in this setting, but valve tissue PCR (when surgery was performed) frequently confirmed Bartonella in culture-negative cases.
A case-control study from South America found a striking association between Bartonella PCR positivity in blood and cardiac disease. Compared with controls, the risk of being PCR positive was many times higher in patients with endocarditis, arrhythmias, and Chagas cardiomyopathy. The study does not prove Bartonella caused these conditions, but the association is large enough that it deserves attention when standard cardiac infectious workups come back empty.
In a controlled comparison of adults with psychosis from a single research group using their proprietary enrichment culture platform, Bartonella DNA was detected in the blood of 43.2% of patients versus 14.3% of unaffected controls. The authors of that work are careful to say this association does not establish that Bartonella causes psychosis or contributes to disease progression. It is an association in a specific cohort, and the findings have not yet been replicated by independent laboratories.
Case reports describe persistent Bartonella bacteremia in patients with vasculitis, cerebral infarction, pediatric acute-onset neuropsychiatric syndrome, and other neurologic syndromes, with improvement in some patients after antibiotic therapy. The evidence here is suggestive rather than definitive, and Bartonella blood PCR in these settings is best interpreted alongside symptoms, exposure history, and other testing.
In a study of patients with end-stage liver disease, Bartonella DNA was more often detected in those with cryptogenic hepatitis (liver inflammation with no identified cause) than in those with non-viral hepatitis of known cause. Among patients followed at least two years, mortality was higher among those with cryptogenic hepatitis who tested positive for B. henselae.
In one study of febrile HIV-infected patients, Bartonella henselae or B. quintana was isolated or detected by DNA in tissue in 12 of 382 patients (3%). Bacillary angiomatosis (a Bartonella skin condition) and elevated alkaline phosphatase were the clinical features most associated with infection. In immunocompromised patients (including solid organ transplant recipients and people with HIV), blood PCR can be positive even when antibody testing is negative, because impaired immunity may blunt the antibody response. IDSA HIV guidelines note that up to 25% of culture-positive patients with advanced HIV never develop detectable antibodies, which is why direct DNA detection is particularly valuable in this group.
Bartonella DNA shows up in apparently healthy people too. Brazilian blood donor studies confirmed bacteremia in 1.2% to 3.2% by conventional methods and detected DNA in over 20% with multi-assay strategies. Among Spanish sanitary workers, 21.6% had molecular evidence of bloodstream infection, with seroreactivity in 83.1%, and none of these results tracked tightly with self-reported symptoms. Among 114 US veterinarians and technicians, 28% had Bartonella DNA in blood compared with none of the controls.
A positive blood DNA result, then, does not automatically mean you are symptomatic from the infection or that you need treatment. It does raise the question of whether you are an asymptomatic carrier, an early case, or someone whose symptoms have not yet been connected to Bartonella. The bacterium can survive in stored blood for over a month, which is why authors of donor studies repeatedly call for evaluation of transfusion transmission risk, especially for immunocompromised recipients.
Bartonella testing is not a single test, and the options give you different information.
| Test | What It Tells You | Key Limitation |
|---|---|---|
| Blood PCR (this test) | Direct evidence of bacterial DNA in your bloodstream right now | Many false negatives because bacteremia is low and intermittent |
| Serology (IgG, IgM antibodies) | Whether your immune system has seen Bartonella | Can be negative in immunocompromised patients; cross-reacts with Coxiella and related species; positive does not prove active infection |
| Enrichment blood culture plus PCR | Higher yield than direct blood PCR alone for low-level infection | Takes longer; requires specialized lab; still misses cases |
| Tissue or valve PCR | Best yield when an infected site can be biopsied (lymph node, heart valve) | Requires an invasive sample |
In one study of suspected cat-scratch disease, combining blood PCR with serology raised diagnostic yield to 44.4%. Among patients with suspected cat-scratch disease who were seronegative, real-time PCR still detected Bartonella DNA in 7.9% in one series. These numbers reinforce that no single test catches everyone, and combining tests is the most reliable strategy.
If your result is positive and you have symptoms that fit (unexplained fever, heart-valve concerns, lymphadenopathy, certain neuropsychiatric or neurologic syndromes, or you are immunocompromised), the result deserves a focused workup with a clinician familiar with vector-borne and zoonotic infection. That usually means confirming the finding with a second test (such as serology, repeat PCR, or enrichment culture), checking for co-infections that share vectors (Anaplasma, Borreliella, Babesia), and evaluating organs that Bartonella is known to target, particularly the heart and central nervous system.
If your result is positive and you feel well, the result is harder to interpret. Asymptomatic carriage exists, and the right next step is usually repeat testing, careful symptom and exposure review, and discussion with a clinician about whether further workup is warranted. A positive PCR alone, especially in someone without exposure history, is not by itself proof of viable infection or cause of symptoms.
If your result is negative and your suspicion is high, do not stop there. Repeated draws (often three over five to seven days), enrichment culture, alternative specimens such as biopsy tissue, and serology together pick up cases that any single blood PCR will miss. In suspected blood culture-negative endocarditis, the workup typically pairs Bartonella serology and blood PCR with valve tissue PCR if surgery happens.
Bartonella bacteremia is not constant. It rises and falls, and at low ebb the blood can look clean even when infection persists. That makes a single negative reading weaker evidence than most patients realize, and a single positive reading worth confirming. Specialized research labs routinely draw three blood samples over a five to seven day window to raise the chance of catching the bacterium in a positive phase, and several use enrichment culture to coax low-level organisms into detectable numbers.
For someone actively investigating possible Bartonella infection, a reasonable approach is a baseline panel that pairs blood PCR with serology, then repeat testing if clinical suspicion remains high and the first round is negative. After treatment, follow-up PCR can help track whether DNA detection clears, though decisions to retreat should rest on the full clinical picture, not the lab value alone.
This is not a routine screening test for everyone. It earns its place when there is a real clinical or exposure-based reason to ask the Bartonella question. People with culture-negative endocarditis, immunocompromised patients with unexplained fever, those with neurologic or neuropsychiatric symptoms and zoonotic exposure, veterinarians and animal workers with unexplained chronic symptoms, and patients with cat-scratch lymphadenopathy where standard testing is inconclusive are the groups in which the available human evidence supports its use.
Bartonella DNA is best interpreted alongside these tests.